PV Bulletin

Tag archive

Risk Management

publicMedicines and Healthcare products Regulatory Agency · United Kingdom · Updated Jul 3, 2026

Best practice in the labelling and packaging of medicines

Urgency: High

MAHs must update labelling components to meet new criteria, including a minimum font size of 7 points and essential information requirements regarding the medicine's name, strength, route of administration, posology, warnings, and indications as per the guidance. New packaging must be incorporated into stocked products within six months of approval.

LabelingRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Labeling Lead, QPPV
verifiedRegulatory action: Guideline
Read impact briefarrow_forward
publicHealth Canada · Canada · Updated May 23, 2026

Health Canada updates RMP submission guidance effective 1 July 2025

Urgency: High

1) Retrieve and review the updated “Submitting risk management plans guidance document” (PDF) and linked templates referenced from the overview (e.g., RMP note to reviewer, Canadian-specific addendum, RMP summary template) and map deltas vs the superseded 2015 approach. 2) Update Canada submission checklists/work instructions for the 1 July 2025 effective date, including the requirement that the RMP include a summary in English and French and use of the RMP summary attestation/acknowledgment form. 3) Ask Regulatory Intelligence/RA to brief PV leadership on the Agile Licensing notice timeline (RMP provisions in force 1 April 2027) and confirm how transitional provisions will be operationalized for existing RMPs submitted prior to that date.

Label GovernanceRisk ManagementLocal Safety Officer
SOP Impact5 SOPs
ConfidenceHigh
Relevant for: Local Safety Officer, Signal Management Lead, Labeling Lead
verifiedRegulatory action: Country Guides
Read impact briefarrow_forward
publicFda · United Kingdom · Updated May 24, 2026

MHRA updates SaMD/AIaMD guidance, highlighting PCCP and transparency principles

Urgency: High

Ask the safety/device vigilance and PV CSV leads to: (1) confirm whether any marketed/fielded SaMD/AIaMD uses adaptive ML or planned updates that would fit a PCCP-like approach; (2) review current change-control SOPs and technical documentation to ensure change governance and transparency artifacts are captured and retrievable; (3) verify post-market/vigilance processes explicitly account for algorithm updates (e.g., monitoring after updates, escalation criteria).

Risk ManagementDevice VigilanceSignal Management Lead
SOP Impact5 SOPs
ConfidenceMedium
Relevant for: Signal Management Lead, Regulatory Intelligence Lead, Medical Device Vigilance Lead
verifiedRegulatory action: AI/GxP
Read impact briefarrow_forward
publicMhra · Updated Jun 10, 2025

UK MHRA refreshes PV procedures and adds decentralised manufacture UK GVP

Urgency: High

Mhra update requires triage for Signal Validation, Risk Management, Local Affiliate Compliance; confirm local obligations and document follow-up actions.

Signal ValidationRisk ManagementLocal Safety Officer
SOP Impact9 SOPs
ConfidenceMedium
Relevant for: Local Safety Officer, Signal Management Lead, Regulatory Intelligence Lead
verifiedRegulatory action: Country Guides
Read impact briefarrow_forward
publicUpdated May 21, 2026

InSphero acquires PhenoVista, expanding 3D assay and imaging services

Urgency: High

This update requires triage for Risk Management, Vendor Oversight, Inspection Readiness; confirm local obligations and document follow-up actions.

Risk ManagementVendor OversightQPPV
SOP Impact4 SOPs
ConfidenceMedium
Relevant for: QPPV, Signal Management Lead, Labeling Lead
verifiedRegulatory action: Company Watch
Read impact briefarrow_forward
publicTga · Australia · Updated May 22, 2026

TGA safety updates add warnings for GLP-1s, fluoroquinolones, RSV vaccines

Urgency: Medium

Tga update requires triage for Label Governance, Signal Validation, Risk Management; confirm local obligations and document follow-up actions.

Label GovernanceSignal ValidationLocal Safety Officer
SOP Impact6 SOPs
ConfidenceMedium
Relevant for: Local Safety Officer, Signal Management Lead, Labeling Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicUpdated May 21, 2026

WSJ: Japan adds new warnings for Amgen’s Tavneos after deaths

Urgency: Medium

This update requires triage for Label Governance, Signal Validation, Risk Management; confirm local obligations and document follow-up actions.

Label GovernanceSignal ValidationSignal Management Lead
SOP Impact5 SOPs
ConfidenceMedium
Relevant for: Signal Management Lead, Labeling Lead, PV Technology / CSV Lead
verifiedRegulatory action: Latest
Read impact briefarrow_forward
publicEma · Updated May 21, 2026

MaaT Pharma flags CHMP “negative trend” ahead of June vote

Urgency: Medium

Ema update requires triage for Label Governance, Risk Management, AI / GxP Governance; confirm local obligations and document follow-up actions.

Label GovernanceRisk ManagementSignal Management Lead
SOP Impact5 SOPs
ConfidenceMedium
Relevant for: Signal Management Lead, Labeling Lead, Regulatory Intelligence Lead
verifiedRegulatory action: Latest
Read impact briefarrow_forward

Get updates for your PV role

Subscribe to impact-first pharmacovigilance updates. Select every role you want in your digest.

Digest roles: QPPV. Work email only

Tag: Risk Management | PV Bulletin